Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM, identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura… - … journal of cancer, 2013 - Wiley Online Library
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

[引用][C] Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM, identified in papillary thyroid carcinoma

M MATSUSE, N MITSUTAKE… - … journal of cancer …, 2013 - pascal-francis.inist.fr
Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM,
identified in papillary thyroid carcinoma CNRS Inist Pascal-Francis CNRS Pascal and …

Functional characterization of the novel BRAF complex mutation, BRAF (V600delinsYM), identified in papillary thyroid carcinoma.

M Matsuse, N Mitsutake, S Tanimura, T Ogi… - … Journal of Cancer, 2012 - europepmc.org
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

Functional characterization of the novel BRAF complex mutation, BRAF V600delinsYM, identified in papillary thyroid carcinoma.

M Matsuse, N Mitsutake, S Tanimura… - … Journal of Cancer, 2013 - search.ebscohost.com
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

Functional characterization of the novel BRAF complex mutation, BRAF (V600delinsYM), identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura… - … journal of cancer, 2013 - pubmed.ncbi.nlm.nih.gov
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

[PDF][PDF] Functional characterization of the novel BRAF complex mutation, BRAF V600delinsYM, identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura, T Ogi… - academia.edu
The BRAF mutation is the most prevalent genetic alteration in PTCs, ranging 29–83%, 44%
on average. 4 The mutation in PTCs is almost a thymine-to-adenine transversion at …

Functional characterization of the novel BRAF complex mutation, BRAF (V600delinsYM), identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura, T Ogi… - International Journal of …, 2013 - hero.epa.gov
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM, identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura, T Ogi… - International Journal of …, 2012 - infona.pl
An activating mutation in the BRAF gene is the most common genetic alteration in papillary
thyroid carcinomas (PTCs). The mutation in PTCs is almost a c. 1799T> A transversion …

[引用][C] Functional characterization of the novelBRAFcomplex mutation,BRAFV600delinsYM, identified in papillary thyroid carcinoma

M Matsuse, N Mitsutake, S Tanimura, T Ogi… - International Journal of …, 2012 - cir.nii.ac.jp
Functional characterization of the novel<i>BRAF</i>complex mutation,<i>BRAF</i><sup><i>V600delinsYM</i></sup>,
identified in papillary thyroid carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報 …